Recent Advances in the Viral Hepatitis C Treatment
Till now few drugs are available for the treatment of hepatitis C disease. But now newer drug category is included which are direct acting antiviral agents. The mechanism of action of direct acting anti-viral drugs is they are the protein molecules that target specific stages in the hepatitis C virus lifecycle and disturbs the viral replication process there by inhibiting the infection. The drugs included under this category include.
Related Conference of Recent Advances in the Viral Hepatitis C Treatment
October 22-23, 2025
5th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Paris, France
Recent Advances in the Viral Hepatitis C Treatment Conference Speakers
Recommended Sessions
- Advancement in New Drug Discovery for Treatment of Hepatitis
- Critical Care and Hepatology Nursing
- Epidemiology of Hepatitis
- Hepatitis Care
- Hepatocellular Carcinoma
- Intestinal Rehabilitation
- Liver Cancer
- Liver Diseases Diagnosis
- Liver Fibrosis
- Liver Transplantation and Surgery
- Molecular Biology of Hepatitis A, B, C, D and E Viruses
- Pancreatic Diseases
- Pathophysiology of Hepatitis
- Pediatric Gastroenterology, Hepatology and Nutrition
- Pregnancy and Liver Diseases
- Recent Advances in the Viral Hepatitis C Treatment
- Types of Hepatitis
- Viral Hepatitis Management
Related Journals
Are you interested in
- Asthma and Allergy - COPD CONGRESS-2025 (Italy)
- Asthma Management - COPD SUMMIT 2025 (Italy)
- Asthma-COPD Overlap - COPD SUMMIT 2025 (Italy)
- Cardio Pulmonary Disorders - COPD CONGRESS-2025 (Italy)
- Chronic bronchitis - COPD CONGRESS-2025 (Italy)
- Chronic Obstructive Pulmonary Disease - COPD SUMMIT 2025 (Italy)
- Chronic obstructive pulmonary disease - COPD CONGRESS-2025 (Italy)
- Clinical Immunology & Genetics - COPD SUMMIT 2025 (Italy)
- Clinical Trials - COPD SUMMIT 2025 (Italy)
- COPD and Air Pollution - COPD CONGRESS-2025 (Italy)
- COPD Pathogenesis - COPD SUMMIT 2025 (Italy)
- COPD Pathogenesis - COPD CONGRESS-2025 (Italy)
- COPD Preventative Measures - COPD SUMMIT 2025 (Italy)
- COPD-Chronic obstructive pulmonary disease - COPD CONGRESS-2025 (Italy)
- Depression and Anxiety in COPD - COPD SUMMIT 2025 (Italy)
- Depression and Anxiety in COPD - COPD CONGRESS-2025 (Italy)
- Diagnosis and Treatment of COPD - COPD CONGRESS-2025 (Italy)
- Diagnosis and Treatment of COPD - COPD SUMMIT 2025 (Italy)
- Drug Discovery of COPD - COPD CONGRESS-2025 (Italy)
- Drug Discovery of COPD - COPD SUMMIT 2025 (Italy)
- Effect of COVID-19 on Lungs - COPD CONGRESS-2025 (Italy)
- Effect of COVID-19 on Lungs - COPD SUMMIT 2025 (Italy)
- Emphysema - COPD CONGRESS-2025 (Italy)
- Epidemiology - COPD SUMMIT 2025 (Italy)
- Experimental Models - COPD SUMMIT 2025 (Italy)
- Lung and COVID-19 - COPD SUMMIT 2025 (Italy)
- Lung cancer - COPD CONGRESS-2025 (Italy)
- Lung Cancer: Screening, Diagnosis & Treatment - COPD CONGRESS-2025 (Italy)
- Lung Transplantation - COPD SUMMIT 2025 (Italy)
- Lung Transplantation - COPD CONGRESS-2025 (Italy)
- Pathophysiology & Pharmacology - COPD SUMMIT 2025 (Italy)
- Pediatric Neonatal Care in COPD - COPD CONGRESS-2025 (Italy)
- Pediatric Pulmonology & Critical care - COPD CONGRESS-2025 (Italy)
- Pharmacological and Non-Pharmacological Treatments - COPD SUMMIT 2025 (Italy)
- Prevention of COPD - COPD CONGRESS-2025 (Italy)
- Pulmonary diseases - COPD CONGRESS-2025 (Italy)
- Pulmonary Rehabilitation - COPD CONGRESS-2025 (Italy)
- Pulmonary Rehabilitation - COPD SUMMIT 2025 (Italy)
- Respiratory and sleep Medicine - COPD CONGRESS-2025 (Italy)
- Respiratory Failure - COPD SUMMIT 2025 (Italy)
- Respiratory Tract Infections - COPD CONGRESS-2025 (Italy)
- Self-Management and Prevention of COPD - COPD SUMMIT 2025 (Italy)
- Self-Management and Prevention of COPD - COPD CONGRESS-2025 (Italy)
- Spirometry - COPD CONGRESS-2025 (Italy)
- Spirometry - COPD SUMMIT 2025 (Italy)
- Stages & Severity on Lung Diseases - COPD CONGRESS-2025 (Italy)
- Tobacco control - COPD CONGRESS-2025 (Italy)
- Types of COPD - COPD CONGRESS-2025 (Italy)